Everyday Health on MSN

There’s a new drug for motion sickness — the first in 40 years

The FDA approved the pill Nereus (tradipitant) as a new treatment for vomiting caused by motion sickness, with fewer side ...
New Atlas

First new motion sickness drug arrives after nearly half a century

Millions of Americans can now look forward to a better time traveling, with the US Food and Drug Administration (FDA) ...
PharmExec

FDA Approves Nereus for the Prevention of Motion Induced Vomiting

FDA approval of Vanda’s Nereus marks a rare and meaningful regulatory milestone, introducing the first new pharmacologic ...
MedPage Today on MSN

FDA greenlights first motion sickness drug in more than 40 years

The scopolamine skin patch (Transderm Scōp), approved in 1979, was the last drug sanctioned by the FDA to prevent motion ...
Medical Dialogues

FDA Approves Tradipitant as First New Motion Sickness Drug in 40+ Years

The FDA has approved tradipitant (Nereus), an oral NK-1 receptor antagonist, for preventing motion-induced vomiting in adults ...

What's Going On With Vanda Pharmaceuticals Stock Wednesday?

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares are trading higher Wednesday after the company announced it received FDA ...
EconoTimes

Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades

Vanda Pharmaceuticals has received approval from the U.S. Food and Drug Administration (FDA) for its drug tradipitant, ...
Monthly Prescribing Reference

Tradipitant Reduces the Risk of Vomiting Associated With Motion Sickness

Both doses of tradipitant were found to be superior to placebo in preventing vomiting. Tradipitant reduced the risk of vomiting associated with motion sickness in real-world conditions, according to ...
Pharmaceutical Technology on MSN

FDA approves Vanda Pharmaceuticals’ motion sickness drug Nereus

The approval marks the first new pharmacologic treatment in motion sickness in over four decades. The US Food and Drug ...